Remedy for diabetes

Details Remedy for diabetes Remedy for diabetes

2011-04-26

2011-04-26

Weddington, Kevin (Department: 1614)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

C514S866000

Reexamination Certificate

active

07932289

ABSTRACT:
The present invention relates to a therapeutic agent for diabetes with sulfonylurea secondary failure, which contains a GPR40 agonist. According to the present invention, a therapeutic agent for diabetes with sulfonylurea secondary failure that affords a superior insulin secretion effect and a superior hypoglycemic effect even in diabetic patients for whom a sulfonylurea compound or a fast-acting insulin secretagogue fails to provide an insulin secretion effect and therefore, fails to provide a sufficient hypoglycemic effect can be provided.

REFERENCES:
patent: 7456218 (2008-11-01), Yasuma et al.
patent: 2006/0100261 (2006-05-01), Hamamura et al.
patent: 2006/0148858 (2006-07-01), Maekawa et al.
patent: 2006/0258722 (2006-11-01), Yasuma et al.
patent: 1 559 422 (2005-08-01), None
patent: 1 671 649 (2006-06-01), None
patent: 1 698 624 (2006-09-01), None
patent: 1 726 580 (2006-11-01), None
patent: 1 731 505 (2006-12-01), None
patent: WO 02/057783 (2002-07-01), None
patent: WO 03/099793 (2003-12-01), None
patent: WO 2004/022551 (2004-03-01), None
patent: WO 2004/041266 (2004-05-01), None
patent: WO 2004/106276 (2004-12-01), None
patent: WO 2005/032590 (2005-04-01), None
patent: WO 2005/063725 (2005-07-01), None
patent: WO 2005/063729 (2005-07-01), None
patent: WO 2005/087710 (2005-09-01), None
patent: WO 2005/095338 (2005-10-01), None
Fanhanel et al., “Metformin's Effects on Glucose and Lipid Metabolism in Patients with Secondary Failure to Sulfonylureas,” Diabetes Care, vol. 19, No. 11, Nov. 1996, pp. 1185-1189.
Kan et al., “The effect of ultra-rapid-acting insulin secretagogue, nateglinide (Na), in patients with type 2 diabetes that seems to be secondary ineffectiveness of SU drugs,” The Journal of the Japan Diabetic Society, 2000, vol. 43 (Suppl. 1), p. S-120 (with English translation).
Kiyono et al., “Analysis of functional relation of pancreatic β-cell ATP-sensitive K+channels and sulfonylurea receptor, and development of oral antidiabetic drug based on new action mechanism,” Research Papers of the Suzuken Memorial Foundation, 1999, Suzuken Memorial Foundation, 2001, pp. 147-149 (with English translation).
Mimura et al., “Experience of use of rapid-acting postprandial hypoglycemic drug (nateglinide) in type 2 diabetic patients who showed secondary effectiveness of sulfonylurea drugs,” Nippon Taishaitsugaku Zasshi, 2001, vol. 63(1-2), p. 52 (with English translation).
Trischitta et al., “Comparison of Combined Therapies in Treatment of Secondary Failure to Glyburide,” Diabetes Care, vol. 15, No. 4, Apr. 1992, pp. 539-542.
Uemura et al., “Usefulness of thiazolidine derivative in secondary failure to sulfonylurea drugs,” Journal of Japan Diabetic Society, 2001, vol. 44, No. 3, p. 256, 2-S 2-4 (with English translation).
Yamada, Kentaro, “New Strategy of Oral Drug Therapy,” Tonyobyogaku no Shinpo, 2002, vol. 36, pp. 292-296 (with English translation).

Affiliated with

Also associated with

Rating

Remedy for diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Remedy for diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Remedy for diabetes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2620361